PUBLIC CITIZEN for PUBLIC CITIZEN
What was lobbied
12 issue areas, each in the filer's own words, with who lobbied on it and where.
Banking BAN
Consumer financial protections, oppose S 2155-Economic growth, regulatory reform and consumer protection act, HR 4061-Financial stability Oversight Council Improvement act of 2017, HR 4293-Stress Test Improvement Act of 2017, HR 4790-Volcker rule regulatory Harmonization act, Defense of CFPB, consumer lobby day, HR 4439-Modernizing credit opportunity act, Hr 5749-to require the appropriate Federal banking agencies to increase the risk sensitivity of the capital treatment of certain centrally cleared exchange listed options, derivatives and for other purposes, Hr 5793-Housing choice voucher mobility demonstration act of 2018, HR 3861-Federal insurance office reform act of 2017, HR 5054-Small company disclosure simplification act of 2018, HR 5756-To require the SEC to adjust certain resubmission thresholds for shareholder proposals, HR 5877-Main Street Growth Act, HR 5970- To require the SEC to carry out a cost benefit analysis of the use of form 10-Q and other purposes, HR-6130 Helping startups continue to grow act, Stop the auto lending guidance CRA, Fiduciary rule, SEC nomination, disclosure to investors, Oppose the Crapo Bill-Dodd Frank rollbacks, SEC political disclosure, support progressive SEC nominees,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| SUSAN ELAINE HARLEY | — |
| BARTLETT NAYLOR | — |
Civil Rights/Civil Liberties CIV
Congressional Accountability Act work, Antitrust Competition, Sexual harassment/access to justice, Arbitration Fairness Act, Civil Justice issues,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| REMINGTON GREGG | — |
Taxation/Internal Revenue Code TAX
Oppose Johnson amendment rules, support Bright Lines Project legislation, political activity definitions for tax exempt entities, Wall Street Tax/Financial transaction tax, tax reform generally, Opposing additional tax cuts, Country-by-country reporting-opposing national security exemption,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| SUSAN ELAINE HARLEY | — |
| EMILY PETERSON CASSIN | — |
Government Issues GOV
HR 5902/S 2919-Strengthening Office of Government Ethics, S 2482-Foreign Agents Registration Act, Restoring Integrity, Governance, Honesty, and Transparency Act (RIGHT act), HR 5008/S 2695-Inaugural funds, Cybersecurity issues regarding congressional cell phones, REFUSE Act (repelling encroachment by foreigners in US Elections), S 2644-Protect Mueller legislation, A better deal ethics and campaign finance reform package, Protecting the Russia investigation, We the People package, DISCLOSE Act support, Freedom of Information act improvements
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| SUSAN ELAINE HARLEY | — |
| CRAIG HOLMAN | — |
Labor Issues/Antitrust/Workplace LBR
Congressional whistle-blower protections, occupational heat stress protections, safe patient handling, consumer privacy whistle-blower bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNA DEVINE | — |
Pharmacy PHA
S 2011/HR 4138-Medicare Drug Price Negotiation Act, S 974/HR 2212-CREATES Act of 2017, S 124-Preserve Access to Affordable Generics Act, HR 1625-OMNIBUS, opioid addiction data analysis, S 771-Improving access to affordable prescription drugs act, S 252-Medicare Drug Savings act of 2017, S 1369-Stop Price Gouging Act, S 495-Medical innovation and prize fund act, S 1131/HR 2439-FAIR drug pricing act, HR 4117-Competitive Drugs act of 2017, S 771/HR 1776-Improving access to affordable prescription drugs act, S 637-C-THRU Act, S 1347-RxCap Act of 2017, S 1348-SPIKE Act of 2017, HR 5156-Protecting Medicare from Excessive Price Increases Act of 2018, S 2691-Opioid Crisis accountability act of 2018, S 2315-Over the counter drug safety, innovation, and reform act, S 2700/HR 5545-Comprehensive Addiction Resources Emergency (CARE) act, Drug Pricing-Medicare Part D HR 2051-FAST Generics Act of 2017, HR 4116-Transparent Drug Pricing Act, S 2852-Pandemic and All-Hazards Preparedness Act and advancing innovative Act of 2018,
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KNIEVEL | — |
Budget/Appropriations BUD
Oppose Johnson Amendment riders, keeping poison pill riders out of the omnibus,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| EMILY PETERSON CASSIN | — |
Financial Institutions/Investments/Securities FIN
Oppose the Crapo bill, Political spending disclosure, Environmental, Social, governmental disclosure requirement
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
Law Enforcement/Crime/Criminal Justice LAW
Beneficial ownership of corporations and anti-money laundering
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
Consumer Issues/Safety/Products CSP
Regulatory reform, S.J. Res 57, S 2296/HR 4809 Oppose the GOOD Act, consumer financial protections, oppose S 2155, NDAA Act, Amendments related to CFIUS regulations, GOOD Act-provisions related to government transparency
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| SUSAN ELAINE HARLEY | — |
| MATT KENT New | — |
| AMIT NARANG | — |
Trade (domestic/foreign) TRD
NAFTA renegotiation, China 301,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LORI WALLACH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.